Europe Vaccine Adjuvants Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Vaccine Adjuvants Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Vaccine Adjuvants Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Vaccine Adjuvants Market Country Analysis

6.2 Europe Vaccine Adjuvants Market Revenue 2020-2030 (US$ Million)

6.3 Europe Vaccine Adjuvants Market Forecast Analysis

7. Europe Vaccine Adjuvants Market Analysis – by Adjuvant Class

7.1 Mineral Salt Adjuvant

7.1.1 Overview
7.1.2 Mineral Salt Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Emulsion Adjuvant

7.2.1 Overview
7.2.2 Emulsion Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Liposome Adjuvant

7.3.1 Overview
7.3.2 Liposome Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Vaccine Adjuvants Market Analysis – by Type

8.1 Human Vaccine Adjuvant

8.1.1 Overview
8.1.2 Human Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Veterinary Vaccine Adjuvant

8.2.1 Overview
8.2.2 Veterinary Vaccine Adjuvant: Europe Vaccine Adjuvants Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Vaccine Adjuvants Market – Europe (UK, Germany, France, Russia, Italy, Rest of Europe) Analysis

9.1 Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

9.1.1 Europe (UK, Germany, France, Russia, Italy, Rest of Europe): Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.1.1.1 Europe (UK, Germany, France, Russia, Italy, Rest of Europe): Europe Vaccine Adjuvants Market Breakdown, by Adjuvant Class
9.1.1.2 Europe (UK, Germany, France, Russia, Italy, Rest of Europe): Europe Vaccine Adjuvants Market Breakdown, by Type

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 SPI Pharma Inc

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 GSK Plc

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 CSL Ltd

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Seppic SA

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Dynavax Technologies Corp

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 InvivoGen SAS

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Croda International Plc

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Novavax Inc

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Phibro Animal Health Corp

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Vaccine Adjuvants Market

Analysis – by Adjuvant Class (Mineral Salt Adjuvant, Emulsion Adjuvant, Liposome Adjuvant, and Others) and Type (Human Vaccine Adjuvant and Veterinary Vaccine Adjuvant)